Workflow
Stagwell Launches Stagwell Search+: The Industry's First Agentic Platform To Win AI Search
Accessnewswire· 2026-03-02 13:30
New media solution enables brands to win discoverability, visibility, positive sentiment, and outcomes across major AI systems NEW YORK, NY AND LONDON, UK / ACCESS Newswire / March 2, 2026 / Stagwell (NASDAQ:STGW), the global challenger network transforming marketing through AI, today announced the global launch of Stagwell Search+, the industry's first agentic platform for AI Search experiences. Built by Assembly, Stagwell's global omnichannel media agency, in partnership with Emberos, the operating system ...
IceCure Medical Reports Independent Study Published in PLOS One Demonstrating ProSense® Cryoablation Safe and Effective in Treatment of Breast Fibroadenomas
Prnewswire· 2026-03-02 13:30
[https://mma.prnewswire.com/media/2319310/IceCure_Medical_Logo.jpg]SOURCE IceCure Medical## 21% [more press release views with Request a Demo]## Also from this source### IceCure Medical Successfully Completes 5-Year Patient Follow Up in ICESECRET Kidney Cancer Cryoablation Study: Final Analysis Expected in Second Quarter of 2026[IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that...]### IceCure Announces Thomas Hos ...
Twin Vee PowerCats Co. Reports 2025 Financial Results
Accessnewswire· 2026-03-02 13:30
FORT PIERCE, FL / ACCESS Newswire / March 2, 2026 / Twin Vee PowerCats Co. (Nasdaq:VEEE),("Twin Vee" or the "Company"), a manufacturer, distributor, and marketer of power sport boats, today reported financial results for the year ended December 31, 2025, and provided a business update. According to the Company, fiscal 2025 marked a transition year for Twin Vee, as management executed a comprehensive operational reset. ...
Fluent, Inc. to Announce 2025 Fourth Quarter and Full-Year Financial Results and Host Earnings Conference Call on March 9, 2026
Globenewswire· 2026-03-02 13:30
NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Fluent, Inc. (NASDAQ: FLNT) today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2025, after the close of the U.S. financial markets on March 9, 2026. Fluent will host a conference call at 4:30 p.m. ET on the same day to discuss the results. The conference call can be accessed by phone after registering online at Fluent Conference Call or via audio at Audio Registration. The call and accompanying slide prese ...
La Rosa Holdings CEO Provides Letter to Shareholders Outlining Operational Improvements, Reduced Cash Burn and Strategic Initiatives in 2026
Globenewswire· 2026-03-02 13:30
Celebration, FL, March 02, 2026 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech enterprise, today released the following letter to shareholders from its CEO, Joseph La Rosa. To our valued shareholders, Since the beginning of the year, we have taken deliberate and disciplined steps to reposition La Rosa for the next phase of its evolution, one defined by digital infrastructure, artificial intelligence, and operational efficiency. Most notably ...
CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting
Globenewswire· 2026-03-02 13:30
MINNEAPOLIS, March 02, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today the schedule of scientific presentations reviewing the science and outcomes of Barostim therapy at the Technology and Heart Failure Therapeutics 2026 (THT) meeting. THT, the annual conference organized by the Cardiovascular Research Foundation® (CRF®), will b ...
OZOP Energy Solutions, Inc. Announces Addition of Seasoned Beverage Industry Executive Ty Gilmore to Varon Commercial Leadership
Globenewswire· 2026-03-02 13:30
WARWICK, NY, March 02, 2026 (GLOBE NEWSWIRE) -- OZOP Energy Solutions, Inc. (OTC: OZSC, “Company”) today highlighted the addition of Ty Gilmore to the commercial leadership team of Varon. Mr. Gilmore will serve as Chief Revenue Officer of Varon. He is a seasoned beverage industry executive with more than two decades of experience across national accounts, distribution, and operational leadership at large-scale, multi-billion-dollar consumer packaged goods companies. Most recently, Mr. Gilmore served as Pres ...
Adastra Holdings Announces Agreement to Sell Assets and Resignation of Director
TMX Newsfile· 2026-03-02 13:30
Langley, British Columbia--(Newsfile Corp. - March 2, 2026) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) ("Adastra" or the "Company") announces that Adastra Labs Inc. ("Adastra Labs"), a wholly-owned subsidiary of the Company, has entered into an asset purchase agreement dated February 27, 2026 with an arm's length purchaser (the "Purchaser"), pursuant to which Adastra Labs has agreed to sell certain cryoethanol and hydrocarbon extraction and processing equipment as well as packaging and labelling machi ...
SEALSQ to Showcase at Embedded World 2026 Quantum-Resistant Chips and Advanced ASIC Innovations by IC'Alps
Globenewswire· 2026-03-02 13:30
Geneva, Switzerland, March 02, 2026 (GLOBE NEWSWIRE) -- Discover more & book a meeting via: https://www.sealsq.com/embedded-world-2026 SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or the “Company”), a leader in semiconductors, public key infrastructure (PKI), and post-quantum technology hardware and software, today announced its participation in Embedded World 2026, alongside its ASIC (Application Specific Integrated Circuit) design services subsidiary IC’Alps. Embedded Word 2026 event will take place from March ...
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
Globenewswire· 2026-03-02 13:30
HOUSTON, March 02, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the issuance of a new U.S. patent entitled “Fibroblast Cell Therapy for Treatment of Osteoporosis.” The United States Patent and Trademark Office has issued U.S. ...